VILNIP M 1000 Tablet 15’s

Vildagliptin is a powerful oral medication against diabetes in diabetics--termed in the group of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, popularly known as "gliptins." This is specifically designed to help adult patients with Type 2 Diabetes Mellitus manage their blood sugar levels, especially when dietary and exercise modifications are not enough.

Desirable Applications:
Fine Glucose Management: Decreased fasting and postmeal (postprandial) blood sugars.
Weight-Neutral: Vildagliptin very few times causes weight gain in contrast to other antidiabetic drugs.
Low Hypoglycemia Incidence: This exerts the action in a glucose-dependent way affirming that hypoglycemia results from its sole administration goes to a minimum level.
Beta-Cell Support: Studies support it enhancing the abilities of pancreas-bound insulin producing cells.

Actions: On How It Acts
Vildagliptin stands as an inhibitor to DPP-4 enzyme, which is responsible for the ultimate failure of "incretins" (GLP-1 and GIP) that the body releases following meal ingestion. Hence, in keeping high concentrations of these hormones for a prolonged period, Vildagliptin:
Increases production of insulin by the pancreas when blood sugar levels are high.
Reduces hepatic glucose production by lessening glucagon levels.

Optional Use Instructions
Follow-Up: Usually followed on either a 50mg or 100 mg dose once or twice per day under the prescription specified by a healthcare professional.
Administration: Take with or without meals (your choice). It works best when taken at approximately the same time every day to keep a consistent therapeutic level.
Just in the sense of being enhanced in glycemic control, it can also be used with Metformin or Pioglitazone.

Frequently Asked Questions: Vildagliptin (FAQs)

Q: Can Vildagliptin be used for Type 1 Diabetes?
A: No. Vildagliptin is only suitable for Type 2 Diabetes, as its beneficial action depends on specific functional elevation in natural insulin production in promoting the actual process.

Q: Is it safe for patients with kidney issues?
A: Vildagliptin is safe for renal dysfunction patients, because the renal metabolism and ensuing clearance alterations require it with dose adjustment in many cases; always seek advice from your nephrologist or personal doctor for more details.

Q: What are its most prescribed side effects?
A: In general, side effects are rather limited, but for some patients, you should maintain a close observation for mild dizziness, headache, or some instances of nausea. In extremely rare cases, upper respiratory tract infections and sometimes peripheral edema might occur.

Q: Does it cause "low sugar" (hypoglycemia)?
A: While monotherapy may not readily cause hypoglycemia, combinations with insulin or sulfonamides usually result in a hypoglycemic action. Keep glucose tabs or juice available in case of hypoglycemia for combination therapy.

Q: Do I need to stop Vildagliptin when I achieve my sugar levels?
A: Because diabetes is a chronic condition, please do not stop any drug without the advice of your doctor, which could lead to abrupt high glucose levels and related future complications.

Safety & Precautions Profile

Group-Specific Safety Guidelines

Category
Precautionary Advice

Liver Health
The liver function tests (LFTs) should be performed whenever there is a proposed use and should occasionally recur throughout therapy for rearrangement.

Pancreatitis
Stop taking tablets if you ever have a continuous, more-or-less severe abdominal pain.

Pregnancy
Generally not recommended, but your doctor may select the lesser of two evils and give you much safer alternatives to address concomitant pregnancy or lactation periods.

Alcoholic Patients
If you really do like alcohol moderately, you now need to watch your drinking loads of drugs with potential safety hazards: lactic acidosis and extremely fluctuating blood glucose levels.

Summary for Patients
Best for: Good diabetes control.
Key Advantage: Regiments sugar with less weight intervention during and at lows.
Form: Tablet for Oral
Prescription Authorized: Yes.